This inventor holds 1 USPTO granted patent. Top assignees: Isis Innovation Limited, New York University. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1998
Title: Michael J Williams: Innovator in Fibrin-Binding Peptides
Introduction
Michael J Williams is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biochemistry, particularly in the development of fibrin-binding peptide fragments of fibronectin. His work has implications for diagnosing and treating various medical conditions associated with fibrin deposition.
Latest Patents
Williams holds a patent for "Fibrin-binding peptide fragments of fibronectin." This patent includes fibrin-binding molecules that consist of peptide sequences corresponding to specific portions of the natural fibronectin molecule. The first portion includes the F1 module pair of fibronectin, while the second portion includes the F1 module pair of fibronectin as well. The patent also discloses methods for making these peptides and their applications in diagnosing and treating cardiovascular and other related conditions.
Career Highlights
Throughout his career, Michael J Williams has worked with prestigious institutions, including New York University and Isis Innovation Limited. His research has focused on the development of innovative solutions in the medical field, particularly in relation to fibrin-binding peptides.
Collaborations
Williams has collaborated with notable professionals in his field, including Martin Baron and Agueda A Rostagno. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Michael J Williams is a distinguished inventor whose work on fibrin-binding peptides has the potential to impact medical diagnostics and treatments significantly. His contributions to the field exemplify the importance of innovation in addressing complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile